Does lung adenocarcinoma eat Yi Ruisha useful

summary

In December 2007, physical examination found that the right upper lobe occupied the space. In January 2008, the operation was carried out. Two months later, it recurred. After chemotherapy and radiotherapy with zibinol and gemcitabine, the original lesion was slightly enlarged, with a small amount of pleural effusion and liver converted to a small amount of ascites. Now eat Iressa for more than 20 days. After eating about three or four days from the rash, not obvious. There was no improvement in the others, but dull pain in the proximal part of the liver. Want to know lung adenocarcinoma eat Iressa useful?

Does lung adenocarcinoma eat Yi Ruisha useful

First of all, the effect of simply taking Iressa is not very good. It can be achieved by actively adopting the comprehensive treatment of integrated traditional Chinese and Western medicine to relieve clinical symptoms, prolong life, relieve pain and improve the quality of life. According to clinical experience, some patients through the system of traditional Chinese medicine treatment, cancer has been controlled, survival can be extended.

Secondly, it's best to take it orally for a month before reexamination. Reexamination items include lung CT, tumor markers, blood routine, liver and kidney function, etc. If the lung lesion is stable and does not increase by CT examination, oral administration of the drug can be continued. After oral administration of Iressa is ineffective, chemotherapy or other EGFR-TKI drugs can be considered.

Finally, the effect of traditional Chinese medicine in advanced cancer is better, because the patients with advanced cancer, cancer cells consumption, physical weakness, most of the cancer cells have multiple metastases, western medicine local treatment effect is not good, and patients can not tolerate surgery and chemoradiotherapy, taking traditional Chinese medicine can comprehensively regulate the internal environment, tonify Qi and blood, strengthen the body, effectively control the disease, relieve pain, prolong life

matters needing attention

Lung adenocarcinoma has high malignancy and poor prognosis. About 80% of the patients died within one year after diagnosis. The median survival time was about 6 months, including 4-9 months for adenocarcinoma, 5 months for small cell carcinoma and 7-8 months for squamous cell carcinoma. The overall 5-year survival rate of lung cancer patients is only 5% - 10%. Therefore, the key to improve the 5-year survival rate is to find lung cancer early and adopt comprehensive treatment mainly by surgery as soon as possible